Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Gitterman Wealth Management LLC

Gitterman Wealth Management LLC cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 10.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 628 shares of the biotechnology company’s stock after selling 72 shares during the quarter. Gitterman Wealth Management LLC’s holdings in Axon Enterprise were worth $373,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Geode Capital Management LLC raised its stake in shares of Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after buying an additional 35,320 shares during the period. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the period. Champlain Investment Partners LLC grew its holdings in shares of Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after purchasing an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after purchasing an additional 9,090 shares during the period. Finally, Groupama Asset Managment acquired a new position in Axon Enterprise during the 3rd quarter worth about $200,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares in the company, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,370 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total transaction of $875,621.80. Following the completion of the sale, the insider now owns 125,950 shares of the company’s stock, valued at approximately $80,499,683. This represents a 1.08 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $556.26 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $593.42 and a 200-day simple moving average of $535.46. The stock has a market cap of $42.62 billion, a PE ratio of 143.74, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Wall Street Analyst Weigh In

AXON has been the topic of a number of analyst reports. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.